Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction.

Míreanna comhchosúla

• ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither
  de réir: Baigent, C, et al.
  Foilsithe / Cruthaithe: (1998)
• RANDOMIZED TRIAL OF HIGH-DOSE INTRAVENOUS STREPTOKINASE, OF ORAL ASPIRIN, AND OF INTRAVENOUS HEPARIN IN ACUTE MYOCARDIAL-INFARCTION
  de réir: Collins, R, et al.
  Foilsithe / Cruthaithe: (1987)
• ISIS-2 - 4-YEAR MORTALITY FOLLOW-UP OF 17,187 PATIENTS AFTER FIBRINOLYTIC AND ANTIPLATETLET THERAPY IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION
  de réir: Baigent, C, et al.
  Foilsithe / Cruthaithe: (1993)
• Clinical effects of anticoagulants in suspected acute myocardial infarction - Reply
  de réir: Collins, R, et al.
  Foilsithe / Cruthaithe: (1997)
• Benefit of heparin plus aspirin vs aspirin alone in unstable angina.
  de réir: Collins, R, et al.
  Foilsithe / Cruthaithe: (1996)